HARVARD BIOSCIENCE INC — Director's Dealing 2013

Jun 4, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2013-05-31

Reporting Person: McNaughton Thomas (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-05-31	Common Stock	A	19337	—	Acquired	146420	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-05-31	Stock option (right to buy)	$5.08	A	37222	Acquired	2023-05-31	Common Stock, par value $0.01 per share (37222)	Direct

Footnotes

F1: Includes a deferred stock award of 19,337 restricted stock units which vest in equal installments on Jan 1, 2014, Jan 1, 2015, Jan 1, 2016, and Jan 1, 2017.

F2: Includes (a) a deferred stock award of 16,700 restricted stock units which shall vest on Jan 1, 2014; (b) a deferred stock award of 12,500 restricted stock units which vest in equal installments on Jan 1, 2014 and Jan 1, 2015; (c) a deferred stock award of 30,954 restricted stock units which vest in equal installments on Jan 1, 2014, Jan 1, 2015, and Jan 1, 2016; (d) a deferred stock award of 19,337 restricted stock units which vest in equal installments on Jan 1, 2014, Jan 1, 2015, Jan 1, 2016, and Jan 1, 2017; and (e) 66,929 shares of common stock held by Mr. McNaughton.

F3: The options vest in four equal installments on the first four anniversaries of Jan 1, 2013.